107 related articles for article (PubMed ID: 15486372)
1. Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD.
Beeh KM; Beier J; Koppenhoefer N; Buhl R
Chest; 2004 Oct; 126(4):1116-22. PubMed ID: 15486372
[TBL] [Abstract][Full Text] [Related]
2. Sputum levels of reduced glutathione increase 24 hours after allergen challenge in isolated early, but not dual asthmatic responders.
Beier J; Beeh KM; Semmler D; Buhl R
Int Arch Allergy Immunol; 2004 Sep; 135(1):30-5. PubMed ID: 15286443
[TBL] [Abstract][Full Text] [Related]
3. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of glutathione in induced sputum of patients with mild or moderate allergic asthma.
Beier J; Beeh KM; Semmler D; Beike N; Buhl R
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):459-63. PubMed ID: 15104199
[TBL] [Abstract][Full Text] [Related]
5. [Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease].
Chen YH; Yao WZ; Geng B; Ding YL; Lu M; Zhao MW; Tang CS
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):694-7. PubMed ID: 16255955
[TBL] [Abstract][Full Text] [Related]
6. Correlation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patients.
Ziora D; Dworniczak S; Kaczmarczyk G; Jastrzebski D; Krzywiecki A; Kozielski J
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):791-9. PubMed ID: 18204193
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in expired breath condensate of patients with COPD.
Kostikas K; Papatheodorou G; Psathakis K; Panagou P; Loukides S
Chest; 2003 Oct; 124(4):1373-80. PubMed ID: 14555568
[TBL] [Abstract][Full Text] [Related]
8. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD.
Kanazawa H; Yoshikawa J
Chest; 2005 Nov; 128(5):3191-7. PubMed ID: 16304261
[TBL] [Abstract][Full Text] [Related]
9. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].
Cheng Z; Kang Y; Wu QG; Dai LL; Song YN; Xia J; Si JM; Chen CY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):2981-4. PubMed ID: 22333024
[TBL] [Abstract][Full Text] [Related]
10. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde.
Antus B; Harnasi G; Drozdovszky O; Barta I
Respirology; 2014 Jan; 19(1):74-9. PubMed ID: 23834671
[TBL] [Abstract][Full Text] [Related]
11. Induced sputum methodology: Validity and reproducibility of total glutathione measurement in supernatant of healthy and asthmatic individuals.
Beier J; Beeh KM; Kornmann O; Buhl R
J Lab Clin Med; 2004 Jul; 144(1):38-44. PubMed ID: 15252406
[TBL] [Abstract][Full Text] [Related]
12. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
Zhang XJ; He SH; Xie H; Wei JF; Liu CT
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
[TBL] [Abstract][Full Text] [Related]
13. Evidence of lower oxidative stress in the air spaces of patients with reversible COPD.
Serviddio G; Carpagnano GE; Rollo T; Tamborra R; Foschino Barbaro MP; Vendemiale G; Altomare E
Int J Immunopathol Pharmacol; 2006; 19(3):617-28. PubMed ID: 17026847
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
15. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma.
Kostikas K; Gaga M; Papatheodorou G; Karamanis T; Orphanidou D; Loukides S
Chest; 2005 May; 127(5):1553-9. PubMed ID: 15888827
[TBL] [Abstract][Full Text] [Related]
17. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
18. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
